{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06356311",
            "orgStudyIdInfo": {
                "id": "2870-015"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-505423-31",
                    "type": "REGISTRY",
                    "domain": "EU CT"
                },
                {
                    "id": "U1111-1291-7109",
                    "type": "OTHER",
                    "domain": "UTN"
                },
                {
                    "id": "MK-2870-015",
                    "type": "OTHER",
                    "domain": "Merck Id"
                },
                {
                    "id": "jRCT2031240133",
                    "type": "REGISTRY",
                    "domain": "Japan Registry of Clinical Trials (jRCT)"
                }
            ],
            "organization": {
                "fullName": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)",
            "officialTitle": "A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician's Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma)",
            "acronym": "TroFuse-015",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-to-evaluate-sacituzumab-tirumotecan-mk-in-advanced-metastatic-gastroesophageal-adenocarcinoma-mk"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2024-05-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-01-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-05-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-04",
            "studyFirstSubmitQcDate": "2024-04-04",
            "studyFirstPostDateStruct": {
                "date": "2024-04-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will compare how safe and effective sacituzumab tirumotecan is versus the treatment of physician's choice (TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumotecan is superior to TPC with respect to Overall Survival (OS)."
        },
        "conditionsModule": {
            "conditions": [
                "Gastroesophageal Cancer"
            ],
            "keywords": [
                "Gastroesophageal cancer",
                "Gastroesophageal adenocarcinoma",
                "Gastric adenocarcinoma",
                "Esophageal adenocarcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 450,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Sacituzumab tirumotecan",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive sacituzumab tirumotecan at a dose of 4mg/kg by intravenous (IV) infusion on days 1, 15, and 29 of every 42-day cycle.",
                    "interventionNames": [
                        "Biological: Sacituzumab tirumotecan",
                        "Drug: Rescue medication",
                        "Drug: Supportive care measures"
                    ]
                },
                {
                    "label": "Treatment of Physician's Choice (TPC)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "TPC include either trifluridine-tipiracil (35 mg/m\\^2 orally (PO) twice a day (BID) on days 1 to 5 and 8 to 12 of every 28-day cycle), irinotecan (150 mg/m\\^2 IV on days 1 and 15 of every 28-day cycle), paclitaxel (80 mg/m\\^2 IV on days 1, 8, and 15 of every 28-day cycle), or docetaxel (75 mg/m\\^2 IV on day 1 of every 21-day cycle).",
                    "interventionNames": [
                        "Drug: Trifluridine-Tipiracil",
                        "Drug: Irinotecan",
                        "Drug: Paclitaxel",
                        "Drug: Docetaxel",
                        "Drug: Supportive care measures"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Sacituzumab tirumotecan",
                    "description": "Participants will receive sacituzumab tirumotecan as 4mg/kg IV infusion on days 1, 15, and 29 of every 42-day cycle.",
                    "armGroupLabels": [
                        "Sacituzumab tirumotecan"
                    ],
                    "otherNames": [
                        "SKB264. MK-2870"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Trifluridine-Tipiracil",
                    "description": "Trifluridine-tipiracil will be administered at 35 mg/m\\^2 as tablet orally twice a day on days 1-5 and 8-12 of every 28-day cycle.",
                    "armGroupLabels": [
                        "Treatment of Physician's Choice (TPC)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Irinotecan",
                    "description": "Irinotecan will be administered at a dose of 150 mg/m\\^2 by IV infusion on days 1 and 15 of every 28-day cycle.",
                    "armGroupLabels": [
                        "Treatment of Physician's Choice (TPC)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Paclitaxel",
                    "description": "Paclitaxel will be administered at a dose of 80 mg/m\\^2 by IV infusion on days 1, 8 and 15 of every 28-day cycle.",
                    "armGroupLabels": [
                        "Treatment of Physician's Choice (TPC)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Docetaxel",
                    "description": "Docetaxel will be administered at a dose of 75 mg/m\\^2 by IV infusion on day 1 of a 21-day cycle.",
                    "armGroupLabels": [
                        "Treatment of Physician's Choice (TPC)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Rescue medication",
                    "description": "Participants are allowed to take rescue medication for stomatitis or oral mucositis. At the discretion of the investigator, participants are provided with a prescription for rescue medications. Recommended rescue medications are antihistamine, histamine-2 (H2) receptor antagonist, acetaminophen or equivalent, dexamethasone or equivalent infusion or steroid mouthwash (dexamethasone or equivalent), antiemetic medications, oral nystatin suspension or antifungal medications, antidiarrheal agents, antiemetic agents, opiate and non-opiate analgesic agents, appetite stimulants, and granulocyte and erythroid growth factors.",
                    "armGroupLabels": [
                        "Sacituzumab tirumotecan"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Supportive care measures",
                    "description": "Participants are allowed to take supportive care measures for the management of adverse events associated with study intervention at the discretion of the investigator. Supportive care measures may include but are not limited to antidiarrheal agents, antiemetic agents, opiate and non-opiate analgesic agents, appetite stimulants, and granulocyte and erythroid growth factors.",
                    "armGroupLabels": [
                        "Sacituzumab tirumotecan",
                        "Treatment of Physician's Choice (TPC)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Overall Survival (OS)",
                    "description": "OS is defined as the time from randomization to death due to any cause.",
                    "timeFrame": "Up to ~ 31 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Progression-free survival (PFS)",
                    "description": "PFS is defined as the time from randomization to the first documented progressive disease (PD) or death due to any cause, whichever occurs first as assessed by Response Criteria in Solid Tumors Version 1.1 (RECIST 1.1). PD is defined as \u226520% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of \u22655 mm. The appearance of one or more new lesions is also considered PD. PFS as assessed by blinded independent central review (BICR) will be presented.",
                    "timeFrame": "Up to ~ 25 months"
                },
                {
                    "measure": "Objective Response Rate (ORR)",
                    "description": "ORR is defined as the percentage of participants with CR (disappearance of all target lesions) or PR (at least a 30% decrease in the sum of diameters of target lesions) per RECIST 1.1. The percentage of participants who experience CR or PR as assessed by BICR will be presented.",
                    "timeFrame": "Up to ~ 25 months"
                },
                {
                    "measure": "Duration of Response (DOR)",
                    "description": "For participants who demonstrate a confirmed CR (disappearance of all target lesions) or PR (at least a 30% decrease in the sum of diameters of target lesions) per RECIST 1.1, DOR is defined as the time from first documented evidence of CR or PR until PD or death. Per RECIST 1.1, PD is defined as at least a 20% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. The appearance of one or more new lesions is also considered PD. DOR as assessed by BICR will be presented.",
                    "timeFrame": "Up to ~ 48 months"
                },
                {
                    "measure": "Number of Participants Who Experience an Adverse Event (AE)",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention.",
                    "timeFrame": "Up to ~ 48 months"
                },
                {
                    "measure": "Number of Participants Who Discontinue Study Intervention Due to an AE",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study intervention.",
                    "timeFrame": "Up to ~ 48 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Has a histologically-or cytologically-confirmed diagnosis of advanced, unresectable or metastatic gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, or esophageal adenocarcinoma\n* Has received, and progressed on, at least 2 prior chemotherapy and/or immunotherapy regimens\n* Participants are eligible regardless of human epidermal growth factor receptor-2 (HER2) status. Participants who are HER2+ must have previously received trastuzumab where available/appropriate\n* Has adequate organ function\n* Has provided tumor tissue sample for determination of trophoblast cell-surface antigen 2 (TROP2) status by the central laboratory before randomization for stratification\n* Participants who have AEs due to previous anticancer therapies must have recovered to Grade \u22641 or baseline (except for alopecia and vitiligo). Participants with endocrine related AEs who are adequately treated with hormone replacement therapy are eligible\n* Has measurable disease per Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 as assessed by the local site investigator/radiology\n* Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 3 days before randomization\n* Has ability to swallow oral medication for those who may receive trifluridine-tipiracil\n* Human immunodeficiency virus (HIV) infected participants must have well-controlled HIV on antiretroviral therapy (ART)\n* Hepatitis B surface antigen (HBsAg) positive participants are eligible if they have received hepatitis B virus (HBV) antiviral therapy and have undetectable HBV viral load\n* Participants with a history of hepatitis C virus (HCV) infection are eligible if HCV viral load is undetectable\n\nExclusion Criteria:\n\n* Has a history of documented severe dry eye syndrome, severe Meibomian gland disease and/or blepharitis, or corneal disease that prevents/delays corneal healing\n* Has Grade \u22652 peripheral neuropathy\n* Has active inflammatory bowel disease requiring immunosuppressive medication or previous history of inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis, or chronic diarrhea)\n* Has uncontrolled, significant cardiovascular disease or cerebrovascular disease, including New York Heart Association Class III or IV congestive heart failure, unstable angina, myocardial infarction, uncontrolled symptomatic arrhythmia, prolongation of corrected QT interval (QTcF) to \\>480 ms, and/or other serious cardiovascular and cerebrovascular diseases within 6 months before the first dose of study intervention\n* Has accumulation of pleural, ascitic, or pericardial fluid requiring drainage or diuretic drugs within 2 weeks before the first dose of study intervention\n* Has received prior treatment with a trophoblast antigen 2(TROP2) targeted antibody-drug conjugate (ADC), a topoisomerase 1 inhibitor based, and/or a topoisomerase 1 inhibitor-based chemotherapy.\n* Has received prior systemic anticancer therapy within 2 weeks before the first dose of study intervention\n* Has received prior radiotherapy within 2 weeks before the first dose of study intervention, has radiation-related toxicities, requiring corticosteroids, and/or has had radiation pneumonitis\n* Has received a live or live-attenuated vaccine within 30 days before the first dose of study intervention\n* Is currently receiving a strong and/or moderate inducer/inhibitor of cytochrome P450 3A4 (CYP3A4) that cannot be discontinued for the duration of treatment with study intervention. The required washout period before starting study intervention is 2 weeks\n* Has received an investigational agent or has used an investigational device within 4 weeks before the first dose of study intervention\n* Has a known additional malignancy that is progressing or has required active treatment within the past 3 years\n* Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis\n* Has an active infection requiring systemic therapy\n* HIV infected participants with a history of Kaposi's sarcoma and/or Multicentric Castlemans's Disease\n* Has concurrent active hepatitis B (defined as hepatitis B surface antigen (HBsAg) positive and/or detectable HBV deoxyribonucleic acid (DNA)) and Hepatitis C virus (HCV) defined as anti-HCV antibody (Ab) positive and detectable HCV ribonucleic acid (RNA)) infection\n* Has had major surgery or significant traumatic injury within 4 weeks before the first dose of study intervention. Anticipation of the need for major surgery during the course of treatment with study intervention is also exclusionary\n* Has severe hypersensitivity (Grades \\>=3) to sacituzumab tirumotecan (MK-2870), any of its excipients, and/or to another biologic therapy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Toll Free Number",
                    "role": "CONTACT",
                    "phone": "1-888-577-8839",
                    "email": "Trialsites@merck.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Merck Sharp & Dohme LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlandoc ( Site 0129)",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32804",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "407-303-5826"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0108)",
                    "status": "RECRUITING",
                    "city": "Marietta",
                    "state": "Georgia",
                    "zip": "30060",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "770-281-5100"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.9526,
                        "lon": -84.54993
                    }
                },
                {
                    "facility": "The West Clinic, PLLC dba West Cancer Center ( Site 0110)",
                    "status": "RECRUITING",
                    "city": "Germantown",
                    "state": "Tennessee",
                    "zip": "38138",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "901-683-0055"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.08676,
                        "lon": -89.81009
                    }
                },
                {
                    "facility": "James Lind Centro de Investigacion del Cancer ( Site 0506)",
                    "status": "RECRUITING",
                    "city": "Temuco",
                    "state": "Araucania",
                    "zip": "4800827",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56994443272"
                        }
                    ],
                    "geoPoint": {
                        "lat": -38.73965,
                        "lon": -72.59842
                    }
                },
                {
                    "facility": "FALP-UIDO ( Site 0500)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "7500921",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "56224457254"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Centro de Estudios Cl\u00ednicos SAGA-CECSAGA ( Site 0503)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "7501010",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56991612199"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Cl\u00ednica UC San Carlos de Apoquindo-Hemato-Oncology ( Site 0502)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "7620002",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "56991290140"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Queen Mary Hospital ( Site 3100)",
                    "status": "RECRUITING",
                    "city": "Hksar",
                    "country": "Hong Kong",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "85291259586"
                        }
                    ]
                },
                {
                    "facility": "Prince of Wales Hospital ( Site 3102)",
                    "status": "RECRUITING",
                    "city": "Shatin",
                    "country": "Hong Kong",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "85235051042"
                        }
                    ],
                    "geoPoint": {
                        "lat": 22.38333,
                        "lon": 114.18333
                    }
                },
                {
                    "facility": "Hillel Yaffe Medical Center ( Site 1604)",
                    "status": "RECRUITING",
                    "city": "Hadera",
                    "zip": "3810101",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "97247776745"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.44192,
                        "lon": 34.9039
                    }
                },
                {
                    "facility": "Rambam Health Care Campus-Oncology Division ( Site 1600)",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "zip": "3109601",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+97247776700"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "Hadassah Medical Center ( Site 1603)",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "zip": "9112001",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "97226777957"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Rabin Medical Center ( Site 1605)",
                    "status": "RECRUITING",
                    "city": "Petah Tikva",
                    "zip": "4941492",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "972522902160"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08707,
                        "lon": 34.88747
                    }
                },
                {
                    "facility": "Sourasky Medical Center ( Site 1602)",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "zip": "64239",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "97236973082"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "National Cancer Center Hospital East ( Site 3300)",
                    "status": "RECRUITING",
                    "city": "Kashiwa",
                    "state": "Chiba",
                    "zip": "277-8577",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+81-4-7133-1111"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.86224,
                        "lon": 139.97732
                    }
                },
                {
                    "facility": "Kochi Medical School Hospital ( Site 3304)",
                    "status": "RECRUITING",
                    "city": "Nankoku",
                    "state": "Kochi",
                    "zip": "783-8505",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+81-88-866-5811"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.56943,
                        "lon": 133.64937
                    }
                },
                {
                    "facility": "Seoul National University Bundang Hospital ( Site 3504)",
                    "status": "RECRUITING",
                    "city": "Seongnam",
                    "state": "Kyonggi-do",
                    "zip": "13620",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "821041671676"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.43861,
                        "lon": 127.13778
                    }
                },
                {
                    "facility": "Seoul National University Hospital-Oncology ( Site 3503)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82220720701"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital, Yonsei University Health System-Medical oncology ( Site 3500)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82222288050"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Asan Medical Center-Department of Oncology ( Site 3501)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "05505",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82230105935"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center-Division of Hematology/Oncology ( Site 3502)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+82-2-3410-6820"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "The Catholic Univ. of Korea Seoul St. Mary's Hospital ( Site 3505)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06591",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "01090566116"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "National Cheng Kung University Hospital-Clinical Trial Center ( Site 3604)",
                    "status": "RECRUITING",
                    "city": "Tainan",
                    "zip": "704",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "886623535354559"
                        }
                    ],
                    "geoPoint": {
                        "lat": 22.99083,
                        "lon": 120.21333
                    }
                },
                {
                    "facility": "National Taiwan University Hospital ( Site 3600)",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "10002",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "886223123456X67514"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Taipei Veterans General Hospital ( Site 3601)",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "112",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "8862287121212573"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Ninewells Hospital and Medical School-Oncology Petty ( Site 2209)",
                    "status": "RECRUITING",
                    "city": "Dundee",
                    "state": "Dundee City",
                    "zip": "DD1 9SY",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "441382496685"
                        }
                    ],
                    "geoPoint": {
                        "lat": 56.46913,
                        "lon": -2.97489
                    }
                },
                {
                    "facility": "The Christie NHS Foundation Trust-Medical Oncology ( Site 2201)",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "m20 4bx",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "447710630514"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Merck Clinical Trials Information",
                    "url": "https://www.merckclinicaltrials.com/"
                },
                {
                    "label": "Plain Language Summary",
                    "url": "https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=2870-015&kw=2870-015"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf",
            "url": "http://engagezone.msd.com/ds_documentation.php"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014271",
                    "term": "Trifluridine"
                },
                {
                    "id": "D000017239",
                    "term": "Paclitaxel"
                },
                {
                    "id": "D000077143",
                    "term": "Docetaxel"
                },
                {
                    "id": "D000077146",
                    "term": "Irinotecan"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000059004",
                    "term": "Topoisomerase I Inhibitors"
                },
                {
                    "id": "D000059003",
                    "term": "Topoisomerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1671",
                    "name": "Irinotecan",
                    "asFound": "Related",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7102",
                    "name": "Dexamethasone",
                    "relevance": "LOW"
                },
                {
                    "id": "M235549",
                    "name": "Dexamethasone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M19537",
                    "name": "Paclitaxel",
                    "asFound": "Sessions",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1668",
                    "name": "Docetaxel",
                    "asFound": "Management",
                    "relevance": "HIGH"
                },
                {
                    "id": "M231",
                    "name": "Albumin-Bound Paclitaxel",
                    "relevance": "LOW"
                },
                {
                    "id": "M2340",
                    "name": "Acetaminophen",
                    "relevance": "LOW"
                },
                {
                    "id": "M9708",
                    "name": "Histamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M17023",
                    "name": "Trifluridine",
                    "asFound": "Dysphagia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11900",
                    "name": "Mitogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M11139",
                    "name": "Loperamide",
                    "relevance": "LOW"
                },
                {
                    "id": "M4249",
                    "name": "Antidiarrheals",
                    "relevance": "LOW"
                },
                {
                    "id": "M9709",
                    "name": "Histamine Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M9710",
                    "name": "Histamine H1 Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M6252",
                    "name": "Clotrimazole",
                    "relevance": "LOW"
                },
                {
                    "id": "M11796",
                    "name": "Miconazole",
                    "relevance": "LOW"
                },
                {
                    "id": "M4254",
                    "name": "Antifungal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M212144",
                    "name": "Histamine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M27371",
                    "name": "Opiate Alkaloids",
                    "relevance": "LOW"
                },
                {
                    "id": "M12697",
                    "name": "Nystatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M29349",
                    "name": "Topoisomerase I Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "Antipy",
                    "name": "Antipyretics"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                }
            ]
        }
    },
    "hasResults": false
}